Sunday, Nov 16th
Last update09:53:53 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
|
 Cancer continues to be one of the world's top causes of death, due in part to... | ||
 A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly... |
 A deadly listeria outbreak connected to prepared pasta meals sold at grocery chains nationwide is worsening,... |
